Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: quidditch who wrote (3022)	5/26/1999 9:56:00 AM
From: David Howe	Respond to of 10280

<< I am assuming you mean 50% p/a. >> Yes, 50% per year. Dave I'll go back to lurking. The new posters got me riled up. The last few weeks have been a bit irritating, if you know what I mean. <g>

To: quidditch who wrote (3022)	5/26/1999 9:58:00 AM
From: jeffbas	Read Replies (1) \| Respond to of 10280

Thank you, Steven. I would have posted the same thing when the price was $140. The price is just more interesting now, and worth paying attention to. Discounting this risky future earnings model to provide an annual return of something like 50% is what a prudent investor should require of this or any other similar investment. As I am neither long or short the stock, I have no agenda except to determine whether I should buy it. Your agenda seems to be to discourage people who suggest that previous valuations were excessive. Do you have some high priced stock hurting you? I believe that $55 1/2 will prove to be the low of this move, absent bad fundamental news on the company or a grinding general market decline to Dow 9000, as some poster's broker was forecasting.